← Back to guidelines
Dermatology35 papers

Melanocytic medullomyoblastoma

Last edited: 4/14/2026

Overview

Congenital melanocytic nevi (CMN) are pigmented lesions present at birth, resulting from the proliferation of melanocytes during fetal development 1. These nevi persist throughout life and can vary in size and number, posing both cosmetic and potential oncologic concerns 2.

Diagnosis

  • Clinical Assessment: Identification based on presence at birth and characteristic appearance 1.
  • Dermoscopy: Utilized for differentiating benign from malignant lesions, recognizing typical patterns associated with benign nevi 5.
  • Photographic Documentation: Helps in monitoring changes over time and comparing parental observations with dermatologist assessments 3.
  • Management

  • Multidisciplinary Approach: Involves pediatricians, dermatologists, psychologists, and surgeons to address cosmetic, psychosocial, and potential oncologic risks 2.
  • Laser Therapy: Combined use of normal mode and Q-switched ruby lasers shows promise for improving pigmentation lightening and clearance 4.
  • Regular Monitoring: Essential for early detection of any malignant transformation, particularly in larger or more numerous nevi 2.
  • Special Populations

  • Pediatrics: Requires careful monitoring and psychological support due to potential psychosocial impacts 2.
  • Cosmetic Considerations: Parents and patients may seek treatment for cosmetic reasons, necessitating dermatological intervention 4.
  • Key Recommendations

  • Employ a multidisciplinary team to manage patients with congenital melanocytic nevi, addressing both medical and psychosocial aspects (Evidence: Strong 2).
  • Regular dermatological evaluations are crucial for monitoring potential malignant transformation, especially in larger nevi (Evidence: Moderate 2).
  • Consider laser therapy, particularly combined modalities, for cosmetic improvement in selected cases (Evidence: Weak 4).
  • Provide psychological support to patients and families to cope with the burden of living with CMN (Evidence: Expert opinion 2).
  • References

    1 . What are congenital melanocytic nevi?. Pediatric dermatology 2024. link 2 Marghoob AA. Congenital melanocytic nevi. Evaluation and management. Dermatologic clinics 2002. link00030-x) 3 Harrison SL, Buettner PG, MacLennan R, Kelly JW, Rivers JK. How good are parents at assessing melanocytic nevi on their children? A study comparing parental counts, dermatologist counts, and counts obtained from photographs. American journal of epidemiology 2002. link 4 Kono T, Nozaki M, Chan HH, Sasaki K, Kwon SG. Combined use of normal mode and Q-switched ruby lasers in the treatment of congenital melanocytic naevi. British journal of plastic surgery 2001. link 5 Rao BK, Wang SQ, Murphy FP. Typical dermoscopic patterns of benign melanocytic nevi. Dermatologic clinics 2001. link70265-5) 6 Magana-Garcia M, Ackerman AB. What are nevus cells?. The American Journal of dermatopathology 1990. link

    Original source

    1. [1]
      What are congenital melanocytic nevi? Pediatric dermatology (2024)
    2. [2]
      Congenital melanocytic nevi. Evaluation and management.Marghoob AA Dermatologic clinics (2002)
    3. [3]
    4. [4]
      Combined use of normal mode and Q-switched ruby lasers in the treatment of congenital melanocytic naevi.Kono T, Nozaki M, Chan HH, Sasaki K, Kwon SG British journal of plastic surgery (2001)
    5. [5]
      Typical dermoscopic patterns of benign melanocytic nevi.Rao BK, Wang SQ, Murphy FP Dermatologic clinics (2001)
    6. [6]
      What are nevus cells?Magana-Garcia M, Ackerman AB The American Journal of dermatopathology (1990)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG